May 3rd, 2016
During the turbulent first quarter of 2016, graduates
from the top MBA programs capitalized on opportunities
to trim their stock holdings, raising billions
of dollars of cash in the process. According to
a recent analysis of Donor Watch's MBA Graduate
Prospect Research List, the top MBAs sold nearly
$2.7 billion in stock during Q1 2016.
the list with the largest stocks sales by their
MBA alumni are the Harvard Business School, the
University of Pennsylvania' Wharton School and
the University of Chicago's Booth School. Combined,
alumni from the three top business schools sold
nearly $700M in stock during Q1.
Overall, HBS's top selling
alumni sold more than $310 million worth of stock
during Q1, with Alan Lafley (Chairman of Procter
& Gamble / PG), Martin Roper (CEO of Boston
Beer / SAM), Marc Casper (CEO of Thermo Fisher
Scientific / TMO), and Gregory Case (CEO of Aon
Corp / AON) leading the list.
The Wharton School's alumni
sold more the $250 million worth of equities,
with Safra Catz (CEO of Oracle / ORCL), Jay Fishman
(Chairman of the Travelers Companies / TRV), John
Bryant (Chairman of Kellogg Company and Jean Jacques
Bienaime (CEO of Biomarin Pharmaceutical / BMRN)
leading the alums.
The other MBA program's
that made the top 10 prospect list are Columbia
Business School, NYU Stern, Northwestern University's
Kellogg, Stanford Graduate School of Business,
UCLA's Anderson School, Berkeley's Haas School
and Cornell's Johnson School.
Some smaller MBA programs also pushed their way into the top 20 list of MBA schools, including: Atlanta University, College of William and Mary, Golden Gate University, Monmouth University, Santa Clara University and Xavier University.
Donor Watch provides
its powerful software platform and real-time analyses
to the development offices and prospect research
teams at leading colleges, universities and nonprofits.
Donor Watch's unique and robust set of research
tools empower fund raisers and prospect researchers
to manage their relationships with top and high
potential donors. For more information
and access, please
sign-up for a free trial today.